Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARBONOMIC: Tumor Metabolism in High-grade Glioma
NCT02305056Phase 1Terminated
- Sponsor
- CHU Grenoble Alpes
- Start
- Sep 2014
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by CHU Grenoble Alpes. Primary endpoint: Mass spectrometry measurement of C13 labelled proteins at 30 hours. Started Sep 2014; status: terminated.
Beyond the preview
Go deeper on NCT02305056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02305056.